Dr. Reddy

FDA OKs Dr. Reddy's Generic Version of Arixtra

The Associated Press
Federal regulators approved a generic version of a blood-clot treatment made by Dr. Reddy's Laboratories, the company said Wednesday.
Dr. Reddy's, based in India, said the approval covers several doses of the fondaparinux sodium injection in prefilled, color-coded single-dose syringes.
It is a generic version of the GlaxoSmithKline blood-clot treatment, Arixtra.

Syndicate content